FDA-Drug2026-09-02Class IIMISBRANDING

Accord Healthcare levothyroxine sodium tablets recalled for subpotent drug

LABEL MIX UPNationwide distributionDrugs

What this means

Accord Healthcare is recalling specific lots of levothyroxine sodium 112 mcg tablets because they contain less active ingredient than labeled. This means patients taking these tablets may not receive the full thyroid hormone dose they need. The recall affects 1000-count bottles distributed nationwide.

  • Check your levothyroxine bottle for lot number D2402443, D2402444, or D2402445 with expiration date 10/31/2026.
  • If you have an affected lot, contact your pharmacy or doctor before stopping or replacing your medication.
  • Do not stop taking levothyroxine without medical guidance, as thyroid hormone replacement is essential.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Subpotent Drug

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the United States
Affected count
N/A
Manufactured in
8041 Arco Corporate Dr Ste 200, N/A, Raleigh, NC, United States
Products
Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-452-17.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0780-2026

More Accord Healthcare recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.